ArticleVaccines2025

Intranasal Sendai Virus Vaccination of Seropositive Children 1 to 2 Years of Age in a Phase I Clinical Trial Boosts Immune Responses Toward Human Parainfluenza Virus Type 1.

Elisabeth Adderson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.